MedWatch

Investor presentation knocked out Rhovac share - CEO calms down investors

A comment on an investor conference cost Danish biotech company Rhovac more than DKK 100 million of its stock market value.

Rhovac CEO Anders Ljungqvist (left) on Sedermeradagen 2018. | Foto: Youtube

Rhovac is investigating the opportunities to continue without a partner.

This is according to a telegram from Finwire after the investor conference Sedermeradagen in Stockholm, Sweden, where the Danish biotech company was among the companies presenting themselves to potential investors.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier